Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,537,000
-$43,332,000 QoQ
Shares Held
3,300,000
-29.8% QoQ
Ownership
3.94%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. EYPT ranks #21 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in EYPT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,537,000 | 3,300,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,869,000 | 4,700,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $79,171,295 | 5,559,782 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,988,000 | 6,800,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,604,000 | 6,200,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $42,837,500 | 5,750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,293,445 | 3,791,420 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,245,354 | 3,591,420 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $98,312,700 | 4,756,299 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $103,218,966 | 4,466,420 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,874,658 | 1,736,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,505,592 | 1,782,252 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,733,000 | 1,950,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,825,000 | 1,950,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,424,500 | 1,950,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,346,500 | 1,950,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,692,500 | 1,950,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,868,000 | 1,950,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,370,783 | 1,763,031 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,384,000 | 1,600,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,425,023 | 1,518,211 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||